09989.HK
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
HKD 3.76
−9.51%Next report
Analyst consensus
- Next report date
- Nov 4, 2026
- EPS estimate
- HKD 0.22
- Revenue estimate
- HKD 2.9B
Latest reported
- Last report date
- Aug 28, 2026
- EPS actual
- HKD 0.07
- EPS estimate
- HKD 0.09
- Revenue actual
- HKD 1.4B
- Revenue estimate
- HKD 1.6B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 0
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -24.7%
- Revenue beats (12Q)
- 0
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 28, 2026 | HKD 0.09 | HKD 0.07 | Miss -24.68% | HKD 1.4B |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 4, 2026